Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

ID#: NCT04427384

Age: Birth - 66+

Gender: All

Healthy Subjects: No

Recruitment Status: Recruiting

Start Date: September 11, 2020

End Date: December 31, 2028

Contact Information:
Lisa Campbell, PhD GT Medical Technologies
(833) 662-0044
Angela Hall GT Medical Technologies
Summary: The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.
Eligibility:

Inclusion Criteria:

1. Patients who undergo maximum safe resection of intracranial neoplasm(s) AND implantation of GammaTiles.

2. Willing and able to provide informed consent and to participate in all evaluations.

Exclusion Criteria:

1. Inability to undergo pre-operative and post-operative imaging for disease and implant assessment.

2. Major medical or psychiatric illness, which, in the investigator's opinion would prevent completion of treatment, ability to complete assessments at the time of enrollment, and/or interfere with follow ups.

3. Lack of English language fluency sufficient to allow for completion of neurocognitive and QOL tests (which are in English).